Publication Name	World Journal of Respirology
Manuscript ID	22849
Country	United States

Received	2015-09-28 17:13
Peer-Review Started	2015-09-28 20:42
To Make the First Decision	2015-11-24 14:53
Return for Revision	2015-11-30 15:27
Revised
Second Decision	2016-03-07 15:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-03-16 16:10
Articles in Press	2016-03-16 16:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-21 17:54
Publish the Manuscript Online	2016-03-25 15:05

ISSN	2218-6255 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Respiratory System
Manuscript Type	Review
Article Title	Lung cancer screening: Should we be excluding people with previous malignancy?
Manuscript Source	Invited Manuscript
All Author List	Cherie P Erkmen, Larry R Kaiser and Ashley L Ehret
Funding Agency and Grant Number
Corresponding Author	Cherie P Erkmen, MD, Associate Professor of Surgery, Director of The Temple-Fox Chase Lung Cancer Screening Program, Department of Thoracic Medicine and Surgery, Temple University Health System, 3401 North Broad Street, Philadelphia, PA 19140, United States. cherie.p.erkmen@tuhs.temple.edu
Key Words	Lung cancer screening; Criteria; Previous malignancy; Antecedent malignancy; Lung metastasis; Guidelines; Head and neck cancer; Lung cancer; Low dose computed tomography; Gastric cancer; Breast cancer; Colorectal cancer; Lymphoma; Esophageal cancer
Core Tip	Most lung cancer screening trials, including the National Lung Screening Trial, exclude those with a history of a previous malignancy as it may introduce confounding factors that influence survival. However, people with previous malignancy may benefit from the discovery of treatable lung cancer as well as treatable metastasis. In this review, we summarize the consideration that studies and national guidelines give in regards to lung cancer screening in patients with previous malignancy. Furthermore, we address the implications of lung cancer screening in the setting of specific malignancies, namely lung, head and neck, esophageal, gastric, breast, colorectal cancer and lymphoma.
Publish Date	2016-03-25 15:05
Citation	Erkmen CP, Kaiser LR, Ehret AL. Lung cancer screening: Should we be excluding people with previous malignancy? World J Respirol 2016; 6(1): 1-13
URL	http://www.wjgnet.com/2218-6255/full/v6/i1/1.htm
DOI	http://dx.doi.org/10.5320/wjr.v6.i1.1

Full Article (PDF)	WJR-6-1.pdf
Full Article (Word)	WJR-6-1.doc
Manuscript File	22849-Review.docx
Answering Reviewers	22849-Answering reviewers.pdf
Audio Core Tip	22849-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22849-Conflict-of-interest statement.pdf
Copyright License Agreement	22849-Copyright assignment.pdf
Peer-review Report	22849-Peer-review(s).pdf
Scientific Misconduct Check	22849-Scientific misconduct check.pdf
Scientific Editor Work List	22849-Scientific editor work list.pdf